S
Solmaz Maleki Dizaj
Researcher at Tabriz University of Medical Sciences
Publications - 127
Citations - 4914
Solmaz Maleki Dizaj is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 26, co-authored 79 publications receiving 2836 citations. Previous affiliations of Solmaz Maleki Dizaj include University of Tabriz.
Papers
More filters
Journal ArticleDOI
Antimicrobial activity of the metals and metal oxide nanoparticles
Solmaz Maleki Dizaj,Farzaneh Lotfipour,Mohammad Barzegar-Jalali,Mohammad Hossein Zarrintan,Khosro Adibkia +4 more
TL;DR: Books indicated that the particle size was the essential parameter which determined the antimicrobial effectiveness of the metal nanoparticles, and further studies should be performed to minimize the toxicity of metal and metal oxide nanoparticles to apply as proper alternatives for antibiotics and disinfectants especially in biomedical applications.
Journal ArticleDOI
Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.
TL;DR: The influence of size, shape, the surface modification of nano particles, medium, and cell division effects on the cellular absorption of drug/gene nanocarriers is reviewed.
Journal ArticleDOI
Antimicrobial Activity of Carbon-Based Nanoparticles
TL;DR: The antimicrobial activity of carbon-based nanostructures may interestingly be investigated in the near future owing to their high surface/volume ratio, large inner volume and other unique chemical and physical properties.
Journal ArticleDOI
Calcium carbonate nanoparticles as cancer drug delivery system
Solmaz Maleki Dizaj,Mohammad Barzegar-Jalali,Mohammad Hossein Zarrintan,Khosro Adibkia,Farzaneh Lotfipour +4 more
TL;DR: According to this review, CaCO3 nanoparticles, owing to their special characteristics, will have a potential role in safe and efficient cancer treatment in future.
Journal ArticleDOI
Applications of nanotechnology in drug delivery to the central nervous system
TL;DR: The evidence on the applications of nanotechnology in designing drug delivery systems with the ability to cross through the blood-brain barrier (BBB) in order to transfer the therapeutic agents to the CNS is reviewed.